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Summary
QUESTIONS UNDER STUDY: Patients with chronic ill-
nesses like diabetes mellitus benefit from care following
the concept of the Chronic Care Model. To improve quality
and to be responsive to patients’ needs reliable data on pa-
tients’ view of care in different healthcare settings are re-
quired. We evaluated the congruency of diabetes care with
the Chronic Care Model between managed and non-man-
aged care organisations from a patient’s perspective.
METHODS: We compared type 2 diabetes patients from
non-managed care with a managed care organisation in
Switzerland. We evaluated differences between these set-
tings with the Patient Assessment of Chronic Illness Care
5A questionnaire (PACIC 5A; scale from 1–5) that com-
bines the PACIC and the 5A-approach of physicians’ coun-
selling.
RESULTS: 374 patients completed the PACIC 5A (326
from non-managed care settings, 48 from managed care).
The adjusted average PACIC summary score was 3.18 in
the non-managed care compared to 3.49 in the managed
care sample (p = 0.046). Managed care patients scored sig-
nificantly higher in the subscales goal setting (2.86 vs 3.29;
p = 0.015), advice (3.23 vs 3.64; p = 0.014), assist (2.98 vs
3.44; p = 0.016) and arrange (2.50 vs 2.88; p = 0.049).
CONCLUSIONS: Our data from different health care set-
tings suggest that managed care is recognised by type 2
diabetes patients as care that is more congruent with the
Chronic Care Model and offers more intense behavioural
counselling and self-management support compared with
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usual primary care in Switzerland. Future research should
evaluate larger, more comparable patient groups.
Key words: primary health care; general practice; health
care organisation; chronic disease; diabetes mellitus;
chronic care model; patient centred care
Introduction
Patients with chronic illnesses like diabetes mellitus benefit
from care following the concept of the Chronic Care Model
(CCM) [1]. This model is based on six core elements:
healthcare organisation, delivery system design, clinical in-
formation systems, decision support, community resources
and self-management support. Together, these elements are
designed to facilitate and produce effective interactions
between proactive primary care practice teams and em-
powered patients with the aim to improve processes and
outcomes in chronic illnesses [2].
Few instruments are available to assess to what extent
provided care is congruent with the CCM. To enable this,
the Assessment of Chronic Illness Care (ACIC) has been
developed [3]. This questionnaire is completed by health-
care team members and is particularly useful for helping
teams to identify gaps and to improve the care process. The
shortcoming of the ACIC is that only the physicians and
institutions perspective is assessed and this does not neces-
sarily reflect how patients view the care they receive. To
overcome this shortage the Patient Assessment of Chronic
Illness Care (PACIC) has been developed to assess congru-
ency of provided health care to the CCM from the patients’
point of view. The original PACIC has been subsequently
expanded in the PACIC 5A with the additional assessment
to what extent physicians’ counselling reflects the 5A-ap-
proach (assess, advise, agree, assist and arrange) [4, 5].
We recently compared the delivery of care for patients with
diabetes between managed care, group and single practices
in Switzerland by using the ACIC. The managed care prac-
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tices scored significantly better than the other practices [6].
The aim of this study was to evaluate the patients’ per-
spective on CCM congruent diabetes care and to assess
to what extent physicians’ counselling reflects the 5A-ap-
proach between non-managed care and managed care
primary practices.
Methods
This study was conducted in a cross sectional study design.
Patient recruitment
Patients from the non-managed care group (non-MCO)
participated in the Chronic Care for diabetes study
(CARAT) [7, 8]. CARAT challenges the hypothesis that
implementing elements of the CCM improves quality of
care and outcomes. These elements change the organisation
of care via trained practice nurses, who provide informa-
tion and skills to patients.
Non-managed care group
A total of 30 primary care practices participated in CARAT,
10 were single practices and 20 were group practices from
the German speaking part of Switzerland. Eligible patients
were identified through the general practitioners’ registry
based on lab results and received an invitation letter from
the general practitioners with information about the study.
Patients were included in consecutive order of attendance
in the practice, regardless of the reason for the encounter.
The inclusion criteria were adulthood (age >18 years), dia-
gnosis of type 2 diabetes mellitus according to international
diagnostic criteria [9] and at least one HbA1c level of
≥7.0% measured within the preceding year. The latter cri-
terion was formulated because the aim of CARAT was to
reduce HbA1c values by 0.5% points considering the cur-
rent recommendations in guidelines (HbA1c = 6.5%) at
study onset. Detailed method and design of the CARAT
study have been published elsewhere [7].
Managed care group
Patients for the managed care organisation group (MCO)
were recruited in consecutive order between February and
May 2011 from the mediX group practice in Zurich. In-
clusion criteria were adulthood (age >18 years) and dia-
gnosis of type 2 diabetes mellitus according to international
diagnostic criteria [9]. The mediX organisation is one of
the first managed care organisations in Switzerland, foun-
ded in 1998. Coordination of care and a team based patient
centred approach is a focus. Information is shared with
patients and by providers, supported by electronic health
records and collaboration within a multiprofessional team
including a diabetes nurse, a nutritionist and another spe-
cialist when needed. In addition an internet-based clinical
information and decision support system for diabetes pa-
tients exists that can be used during consultations. Health
professionals have access to mediX guidelines which fulfill
the demand of evidence base and are based on national and
international guidelines, but are more comprehensive sum-
marising the key elements of management for primary care.
The mediX guidelines are independent from any pharma-
ceutical sponsoring.
Congruence with the Chronic Care Model (CCM) and
the 5A counselling approach from the patients’
perspective
Patients’ assessment of provided care was quantified with
the Patient Assessment of Chronic Illness Care 5A (PACIC
5A) that combines the assessment of care according to the
key elements of the CCM (PACIC) with the patients’ as-
sessment to what extent physicians’ counselling reflects the
5A-approach (assess, advise, agree, assist and arrange) [10,
11]. The “5A” is the recommended approach for behaviour-
al changes according to the US Preventive Services Task
Force (USPSTF) [10]. Glasgow et al. first validated the
PACIC 5A in a sample of diabetes patients in 30 primary
care practices [11]. In the mean time it was validated also
for other chronic conditions, and a German version of the
PACIC 5A is available [5].
The PACIC 5A captures the time period of the last six
months and includes 26 items (the original 20 PACIC items
assessing five scale constructs: patient activation, delivery
system/practice design, goal setting/tailoring, problem
solving/contextual, follow-up/coordination, and six addi-
tional items to produce subscales reflecting each of the 5As
of behavioural counselling). “Patient activation” assesses
to what extent the patient was motivated and supported by
the physician to initiate changes. “Delivery system/practice
design” assesses if the patient was supported e.g., by book-
lets and how satisfied the patient was with the organisa-
tion of care. “Goal setting/tailoring” assesses to what extent
general instructions and suggestions were adapted to the
personal situation. “Problem solving/contextual” addresses
how the physician dealt with problems, which interfered
with achieving predefined goals. Finally, “Follow-up/co-
ordination” addresses how frequently and consistently the
whole process was followed-up. The items are scored on a
5–point Likert scale, ranging from 1 (= never) to full ac-
cordance (5 = always). The PACIC summary score is the
average of items 1–20, the 5A summary score is the aver-
age of items 1–4 and 6–26 (the instrument is available on-
line at: http://improvingchroniccare.org/tools/pacic.htm.).
Data collection and data security
The ethics committee of the Canton of Zurich approved the
study and provided a “certificate of unobjectability”. After
giving informed consent the PACIC 5A questionnaire was
handed out to the patients by the physician or the practice
nurse with a stamped envelope with the postal address of
the study centre. Patients were informed that neither the
physicians nor the practice team had any possibility to be
informed of their answers. An independent research assist-
ant of the university anonymised the data and entered them
directly into SPSS (version 18.0 or higher). All study re-
lated data and documents were stored on a protected serv-
er of the University of Zurich. Only members of the study
team could access the respective files. Intermediate and fi-
nal reports were stored in the office of the Institute of Gen-
eral Practice at the Zurich University Hospital.
Statistical analyses
Continuous variables are presented as means and standard
deviations (±), categorical data as frequencies and percent-
ages. Mean differences between the MCO and non-MCO
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samples were calculated unadjusted using t-tests for inde-
pendent samples and using analysis of covariance adjus-
ted for HbA1c, sex, age, years of education, living situation
and nationality.
Results
Patient characteristics
In total, 374 patients of whom 57.8% were male with a
mean age of 67.8 ± 10.7 years participated in the study.
326 patients were non-MCO study participants, 48 were re-
cruited from the MCO. Table 1 shows patient character-
istics for both groups. Non-MCO study participants were
younger and had a higher HbA1c level (≥ one HbA1c level
of ≥7.0% measured in the preceding year was an inclusion
criterion). More patients in this group were still working.
The percentage of immigrants was higher in the MCO pop-
ulation. Patients from the two samples did not significantly
differ in terms of gender, education, living together with a
partner or family (table 1).
PACIC and 5A scores
The adjusted average PACIC summary score was 3.18 (SE
= 0.05) in the non-MCO study sample compared to 3.49
(SE = 0.14) in the MCO sample. This difference was stat-
istically significant (p = 0.046). MCO patients also scored
higher than non-MCO participants in the five PACIC sub-
scales with significance for the subscale goal setting.
For the adjusted average 5A summary score as well as
for the 5A subscores, again a trend for higher scores in
the MCO sample was detectable. Patients treated in MCO
compared to the non-MCO study participants reported stat-
istically significant higher values for the advice, assist and
arrange subscales (table 2).
We also compared our MCO sample with the PACIC 5A
data originally published by Glasgow et al. (2005) [4] in-
cluding a sample of 363 diabetes type 2 patients. Patients in
Glasgow’s study were younger compared to our population
(64.1 ± 11.9 vs 67.8 ± 10.7 years) and more patients were
female than patients in our samples (52.8% vs. 42.2%). The
patients from our MCO sample scored higher in the PACIC
summary score and all subscores except for follow-up/co-
ordination, where they scored equally. The majority of the
non-MCO population scores in Swiss single and group
practices were comparable to the original scores (table 2).
Discussion
Our results showed that from the patients’ point of view
care varies between traditional Swiss primary care prac-
tices and a managed care organisation for patients with dia-
betes type 2. The extent to which type 2 diabetes patients
report having received CCM appropriate care and behavi-
oural counselling shows discrepancies between the two set-
tings.
In our analyses the mean PACIC summary score was com-
parable between the original U.S. primary care study pop-
ulation and the Swiss non-MCO sample, but patients from
the Swiss MCO sample scored significantly higher in the
PACIC summary score compared to Swiss non-MCO pa-
tients. Areas of CCM activities reported less often in the
“usual” Swiss primary care setting were goal setting, prob-
lem solving and follow-up/coordination. This is in accord-
ance with the original validation study with diabetes pa-
tients, where goal setting, problem solving and follow-up
support activities were conducted less often than other ac-
tions [11]. It is of note that for goal setting and for the
three important behavioural counselling elements advice,
assist and arrange patients from the MCO reported signi-
ficantly higher scores. The latter reflecting more intense
self-management support in MCO than in the usual Swiss
primary care setting and in the original publication report-
ing on type 2 diabetes patients from 30 primary care prac-
tices throughout Colorado [11].
A large cross-sectional study from Germany assessed usual
primary care versus a disease management programme
(DMP) in type 2 diabetes patients comparable to our study
populations. The average overall score on the PACIC for
the patients in the DMP versus usual care group was statist-
ically significant higher. Significant differences were also
found for all five subscales of the PACIC and for the 5A
summary and subscales with the highest mean difference
for the assist subscale [12]. These results are similar to ours
comparing usual care with managed care; however, with
higher average scores for both of our study populations
compared to the German study populations.
The validity of the PACIC 5A was studied also in other
chronic conditions. Rosemann et al. [5] demonstrated the
PACIC 5A to be a reliable instrument in patients with os-
teoarthritis. Compared to the osteoarthritis patients both
patient groups in our study, usual care and managed care
type 2 diabetes patients, scored higher for the PACIC sum-
mary score and all 5 subscores as well as for the 5A sum-
mary score. One reason could be that patients from our sur-
vey were older than the patients with osteoarthritis. Former
studies on patient satisfaction with care reported that older
Table 1: Patient characteristics between the non-managed care and managed care study samples.
Non-MCO sample (n = 326) MCO sample (n = 48)
Mean ± SD or n (%) Mean ± SD or n (%)
Age (years) 67.0 ± 10.6 73.3 ± 10.3
Male gender (n, %) 187 (57.4) 29 (60.4)
HbA1c (%) 7.7 ± 1.3 7.0 ± 0.6
Nationality Swiss (n, %) 291 (91.8) 38 (79.2)
Living together with partner/family (n, %) 246 (78.3) 29 (65.9)
Still working (n, %) 100 (32.2) 6 (13.6)
Education (years) 11.6 (3.2) 10.6 (2.9)
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patients tend to have a more positive assessment of their
physicians [13, 14]. However, Glasgow, Wagner, and col-
leagues [4] who reported first data on the PACIC from
integrated HMO and patients with a variety of different
illnesses, 16% of whom had diabetes, showed a small influ-
ence of demographic variables on the PACIC scores. The
only difference occurred in the diabetes group with sig-
nificantly higher scores compared to other chronic condi-
tions. It can be assumed that in diabetes, the prime ex-
ample of chronic illness, more sustained emphasis is put
on chronic care elements and that patients with diabetes re-
ceive more frequent follow-up care and self-management
support compared to patients with other chronic diseases,
which could account for the score difference between dif-
ferent chronic conditions.
Clinical implication: Physicians’ counselling and effective
self-management support are crucial for successful care in
chronic diseases [1, 9, 15–18]. Self-management is even
declared as one of the key outcomes in diabetes and other
chronic illnesses [15]. Unfortunately in many health care
settings self-management support is among the manage-
ment activities offered least often or with unwarranted vari-
ations [19]. A recently published work from Switzerland
assessing retrospectively the compliance of GPs and hos-
pital based internists with diabetes treatment guidelines
[20] criticised that non-pharmacological activities, such as
lifestyle education and modification, were reported in less
than half of the patients. Self-management support was not
mentioned at all.
Reported reasons for the gap between recommendation of
self-management support of diabetes patients and offering/
receiving self-management support include the lack of con-
fidence of health professionals in patients self-managing
their own condition, dislike of self-management because
misinterpretation of doctors as being disempowered, lack
of time, and noteworthy in the context of our results, inad-
equate training in decision support, collaborative goal set-
ting and problem solving [19, 21]. Another important reas-
on associated with variation in performance is the degree to
which care is organised and coordinated [22]. In Switzer-
land worries about quality of care exist with managed care
organisations and criticism is raised that a selection of
younger and healthier patients is found in MCOs. Our data
show that from the perspective of type 2 diabetes patients
these worries and criticisms are arbitrary. Our data also re-
flect some of the CCM areas that once implemented result
in improved patient and system outcomes [1, 2] and should
be addressed for future quality improvement work and ef-
fective care redesign in Swiss primary care. Education and
training of health professionals in effective self-manage-
ment support and organising care to facilitate implementa-
tion into daily practice are prime examples for such CCM
areas that need to be attempted. Change concepts could
include regular discussion of improvement strategies and
self-management support to patients within the care team,
regular in-house provider education emphasising the pa-
tient’s central role in managing his or her health and the use
of self-management support strategies that include assess-
ment, goal-setting, action planning and problem-solving.
Table 2: Results for PACIC summary score, 5A summary score and PACIC subscales per non-managed care and managed care patients in comparison to the original
data.
Glasgow et al. (2005) (n =
336)
Non-MCO sample (n = 326) MCO sample (n = 48) p-value
Mean (SD)1) 3.2 (0.9) 3.18 (0.85) 3.39 (0.68) 0.072PACIC summary score
Mean adj. (SE)2) 3.18 (0.05) 3.49 (0.14) 0.046
Mean (SD) 3.6 (1.1) 3.83 (1.13) 3.73 (0.95) 0.519Patient activation
Mean adj. (SE) 3.83 (0.07) 3.85 (0.19) 0.913
Mean (SD) 3.5 (0.9) 3.87 (0.82) 3.98 (0.65) 0.319Delivery system
Mean adj. (SE) 3.88 (0.05) 4.10 (0.14) 0.123
Mean (SD) 3.0 (1.0) 2.86 (0.98) 3.19 (0.82) 0.020Goal setting / tailoring
Mean adj. (SE) 2.86 (0.06) 3.29 (0.16) 0.015
Mean (SD) 3.4 (1.1) 3.26 (1.22) 3.58 (0.88) 0.039Problem solving
Mean adj. (SE) 3.28 (0.07) 3.62 (0.20) 0.116
Mean (SD) 2.9 (1.0) 2.66 (1.05) 2.87 (0.97) 0.229Follow-up / coordination
Mean adj. (SE) 2.66 (0.06) 2.98 (0.18) 0.094
Mean (SD) 3.2 (1.0) 3.09 (0.88) 3.31 (0.71) 0.0995A summary score
Mean adj. (SE) 3.09 (0.05) 3.41 (0.16) 0.055
Mean (SD) 3.3 (1.0) 3.20 (1.07) 3.36 (0.86) 0.257Assess
Mean adj. (SE) 3.20 (0.06) 3.45 (0.18) 0.184
Mean (SD) 3.4 (1.0) 3.68 (0.96) 3.59 (0.91) 0.563Agree
Mean adj. (SE) 3.68 (0.06) 3.75 (0.16) 0.692
Mean (SD) 3.3 (1.0) 3.22 (0.91) 3.50 (0.80) 0.062Advise
Mean adj. (SE) 3.23 (0.05) 3.64 (0.16) 0.014
Mean (SD) 3.1 (1.0) 2.98 (1.05) 3.42 (0.83) 0.002Assist
Mean adj. (SE) 2.98 (0.06) 3.44 (0.18) 0.016
Mean (SD) 2.7 (1.0) 2.51 (1.05) 2.78 (1.01) 0.108Arrange
Mean adj. (SE) 2.50 (0.06) 2.88 (0.18) 0.049
1) Independent sample t-test between non-MCO and MCO sample
2) Based on analysis of covariance adjusted for HbA1c, sex, age, years of education, living situation, nationality
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Strength and limitations
The strength of our study is the objective assessment of the
patients’ perspective of diabetes care with a validated in-
strument that assesses congruence of care with the CCM
and the 5A behavioural counselling approach in different
primary care settings. However, some important limitations
with respect to type and size of study populations, compar-
ability of the populations and generalisability of our res-
ults exist. Two major limitations have to be considered and
discussed in more detail; firstly, the differences in patients’
characteristics and secondly the relationship between small
sample size and small effect size in the MCO group. An in-
clusion criterion for the non-MCO group was at least one
HbA1c level of 7% or higher in the preceding year. This
criterion was not applied to the MCO group. Non-MCO pa-
tients had higher HbA1c levels, were younger and included
a smaller proportion of immigrants compared to MCO pa-
tients. Even the PACIC is not likely to be influenced by
patients’ cultural background, our analysis was adjusted
for these confounders. In addition, patients participating in
the CARAT study reflected our sample of “usual” Swiss
primary care practices. It is known that patients included in
a trial often show better results than patients treated in usu-
al care.
The MCO mediX is one of the first managed care or-
ganisations in Switzerland founded in 1998 with focus on
gate keeping and coordinated care, on a team based patient
centred approach and active quality improvement for
people with chronic illnesses. Particularly for the chosen
condition diabetes, strategies for coordinated care and an
internet-based clinical information and decision aid system
exists. It is possible therefore that our results cannot be
transferred to patients with diabetes in other managed care
organisations. A further limitation is the small sample size
of the MCO and that generalisability is limited. The parti-
cipants in the MCO group were recruited in only one prac-
tice compared to 30 practices recruiting participants for the
non-MCO group. A small sample is more prone to show-
ing significant effects by chance. However, a small sample
size also reduces the power for detecting significant dif-
ferences between the groups. With a larger MCO sample
the differences revealed might therefore have been more
striking. In addition, we cannot exclude a selection bias in
the recruitment of the MCO sample, since these patients
represent only a part of all type 2 diabetes patients treated
in the MCO. However, patients from the sample (n = 48)
differed only slightly from the population of MCO patients
(n = 541) in terms of age (73.3 vs 68 years), gender (32%
vs 39.6% women) and mean HbA1c (7.0% vs 7.3%).
In summary, our data from different health care settings
suggest that managed care is recognised by type 2 diabetes
patients as care that is more congruent with the CCM and
that offers more intense behavioural counselling and self-
management support compared with usual primary care in
Switzerland. Future research should evaluate larger, more
comparable patient groups.
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